1276.HK Earnings — Jiangsu Hengrui Pharmaceuticals Co.,Ltd
HKSE
Updated
When is 1276.HK's next earnings date?
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK) has not announced its next earnings date yet. Its most recent earnings report was on Tuesday, October 27, 2026.
How did 1276.HK do in its last earnings report?
In its most recent report on Oct 27, 2026, Jiangsu Hengrui Pharmaceuticals Co.,Ltd posted EPS of $0.38 versus the $0.39 estimate, a miss of 2.3%. Revenue was $8.42B against a $10.43B estimate.
How much does 1276.HK stock move after earnings?
1276.HK beat EPS estimates in 0 of its last 1 reported quarter.
About Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
🤖 AI Earnings Analysis
Results are weak: revenue of $8.4B missed estimates by $2.0B and EPS of $0.38 fell short by $0.01, pointing to broad-based execution pressure.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | 0.39 | 0.38 | -2.26% | $8.42B | ❌ Miss | — | — | — |
Showing last 1 quarters.